Vardhaman Laboratories Ltd has been delisted from the stock exchange.
Sector
PharmaceuticalsOpen
₹0.51Prev. Close
₹0.49Turnover(Lac.)
₹0Day's High
₹0.51Day's Low
₹0.5152 Week's High
₹052 Week's Low
₹0Book Value
₹0.24Face Value
₹10Mkt Cap (₹ Cr.)
0.21P/E
0EPS
0Divi. Yield
0No Record Found
No Record Found
| Y/e 31 Mar( In .Cr) | Mar-2025 | Mar-2024 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Equity Capital | 4.12 | 4.12 | 4.12 | 4.12 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | -4.02 | -4 | -2.13 | -2.09 |
Net Worth | 0.1 | 0.12 | 1.99 | 2.03 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2018 | Mar-2017 | Mar-2016 | Mar-2015 |
|---|---|---|---|---|
Revenue | 0 | 0 | 0 | 0 |
yoy growth (%) | 0 | 0 | 0 | 0 |
Raw materials | 0 | 0 | 0 | 0 |
As % of sales | 0 | 0 | 0 | 0 |
Employee costs | 0 | 0 | 0 | 0 |
| Y/e 31 Mar( In .Cr) | Mar-2018 | Mar-2017 | Mar-2016 | Mar-2015 |
|---|---|---|---|---|
Profit before tax | -0.04 | -0.03 | -0.03 | -0.02 |
Depreciation | 0 | 0 | 0 | 0 |
Tax paid | 0 | 0 | 0 | 0 |
Working capital | -0.04 | -0.04 | -0.02 | -0.02 |
Other operating items |
| Y/e 31 Mar | Mar-2018 | Mar-2017 | Mar-2016 | Mar-2015 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 0 | 0 | 0 | 0 |
Op profit growth | 1.71 | -6.03 | 43.03 | 42.69 |
EBIT growth | 7.75 | 18.33 | 20.38 | 19.33 |
Net profit growth | 7.75 | 18.33 | 20.38 | 19.33 |
No Record Found
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,840.55 | 147.19 | 4,41,789.55 | 608.7 | 0.87 | 4,887.27 | 93.23 |
Divis Laboratories Ltd DIVISLAB | 6,753.3 | 67.4 | 1,79,450.12 | 756 | 0.44 | 2,793 | 629.49 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 4,451.2 | 68.94 | 1,54,733.87 | 467 | 0 | 2,677 | 249.73 |
Cipla Ltd CIPLA | 1,417.05 | 30.86 | 1,14,182.61 | 384.64 | 0.92 | 3,840.92 | 423.38 |
Dr Reddys Laboratories Ltd DRREDDY | 1,329.35 | 34.53 | 1,11,184.65 | -219.4 | 0.6 | 3,802.6 | 375.78 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman
Dharamchand Shah
Director
Sunil D Shah
Director
Sumedh Shah
Director
Dayanand Naik
Director
Umesh Patil
Director
Rajendra Petare
1393 Peth Bhag,
High School Road,
Maharashtra - 416416
Tel: 91-233-373886/374467/323310
Website: -
Email: vardhaman.lab@gmail.com
C-13 Pannalal Silk,
Mills Cmpd LBS Marg, Bhandup West,
Mumbai - 400 078
Tel: 91-022-25963838
Website: www.linkintime.co.in
Email: rnt.helpdesk@linkintime.co.in/mumbai@linkintime.co.in
Summary
Vardhaman Laboratories Ltd was incorporated on 24th April, 1985 under the Companies Act, 1956, in the State of Maharashtra as Vardhaman Laboratories Private Limited ans subsequently converted into a P...
Read More
Reports by Vardhaman Laboratories Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.